BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15916338)

  • 1. Patient care. Disease dilemma. Can a case be made for programs that improve health, but may not reduce costs?
    Huff C
    Hosp Health Netw; 2005 Apr; 79(4):24, 26. PubMed ID: 15916338
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving primary care for patients with chronic illness: the chronic care model, Part 2.
    Bodenheimer T; Wagner EH; Grumbach K
    JAMA; 2002 Oct; 288(15):1909-14. PubMed ID: 12377092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure disease management programs: not a class effect.
    Fonarow GC
    Circulation; 2004 Dec; 110(23):3506-8. PubMed ID: 15583088
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care).
    Maru S; Byrnes J; Carrington MJ; Chan YK; Thompson DR; Stewart S; Scuffham PA;
    Int J Cardiol; 2015 Dec; 201():368-75. PubMed ID: 26310979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home monitoring should be the central element in an effective program of heart failure disease management.
    Konstam MA
    Circulation; 2012 Feb; 125(6):820-7. PubMed ID: 22331919
    [No Abstract]   [Full Text] [Related]  

  • 6. Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study.
    Pulignano G; Del Sindaco D; Di Lenarda A; Tarantini L; Cioffi G; Gregori D; Tinti MD; Monzo L; Minardi G
    J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):739-47. PubMed ID: 20736784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote care costs for congestive heart failure: a systematic review and meta-analysis of randomized controlled trials in the United States comparing remote versus more intensive care settings.
    Voigt J; Mosier M
    Congest Heart Fail; 2013; 19(4):192-9. PubMed ID: 23279184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of heart failure in the United States: time for a different approach.
    O'Connell JB; Bristow MR
    J Heart Lung Transplant; 1994; 13(4):S107-12. PubMed ID: 7947865
    [No Abstract]   [Full Text] [Related]  

  • 9. Disease management programs: benchmarking costs, savings, ROI.
    Healthc Benchmarks; 1998 Aug; 5(8):117-9. PubMed ID: 10181998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of care coordination on hospitalization, quality of care, and health care expenditures among Medicare beneficiaries: 15 randomized trials.
    Peikes D; Chen A; Schore J; Brown R
    JAMA; 2009 Feb; 301(6):603-18. PubMed ID: 19211468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DM industry confident it can hit Medicare goals.
    Carroll J
    Manag Care; 2005 Sep; 14(9):14, 16. PubMed ID: 16238254
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic case management: Clinical governance with cost reductions.
    Costa ÉS; Hyeda A
    Rev Assoc Med Bras (1992); 2016; 62(3):231-5. PubMed ID: 27310546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CardioMEMS HF for the Management of Heart Failure-Effectiveness and Value.
    Ollendorf DA; Sandhu AT; Pearson SD
    JAMA Intern Med; 2016 Oct; 176(10):1551-1552. PubMed ID: 27599253
    [No Abstract]   [Full Text] [Related]  

  • 14. Judging the value of population-based disease management.
    Rector TS; Venus PA
    Inquiry; 1999; 36(2):122-6. PubMed ID: 10459368
    [No Abstract]   [Full Text] [Related]  

  • 15. Demonstration projects recognize the value of disease management.
    Kozma CM
    Manag Care Interface; 2002 Nov; 15(11):39-40. PubMed ID: 12449901
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging information management technologies and the future of disease management.
    Nobel JJ; Norman GK
    Dis Manag; 2003; 6(4):219-31. PubMed ID: 14736346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of beta blocker therapy for patients with chronic severe heart failure in Ireland.
    Barry M
    Ir Med J; 2002 Jun; 95(6):174, 176-7. PubMed ID: 12171265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disease management programs: Difficulties in the analysis of benefit].
    Linder R; Horenkamp-Sonntag D; Bestmann B; Battmer U; Heilmann T; Verheyen F
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Apr; 58(4-5):345-51. PubMed ID: 25708909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do heart failure disease management programs make financial sense under a bundled payment system?
    Eapen ZJ; Reed SD; Curtis LH; Hernandez AF; Peterson ED
    Am Heart J; 2011 May; 161(5):916-22. PubMed ID: 21570523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can a disease self-management program reduce health care costs? The case of older women with heart disease.
    Wheeler JR; Janz NK; Dodge JA
    Med Care; 2003 Jun; 41(6):706-15. PubMed ID: 12773836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.